Reduced neuronal signaling in the ageing apolipoprotein-E4 targeted replacement female mice

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Yong, Shan May ^a   Lim, Mei Li ^a   Low, Chian Ming ^a   Wong, Boon Seng ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; ISOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LRP1 PROTEIN, MOUSE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TUMOR SUPPRESSOR PROTEIN;

AGING; ANIMAL; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MEMORY; METABOLISM; MOUSE; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

AGING; ANIMALS; APOLIPOPROTEIN E4; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MEMORY; MICE; MICE, TRANSGENIC; NEURONS; PHOSPHORYLATION; PROTEIN ISOFORMS; RECEPTORS, LDL; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84923338451     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06580     Document Type: Article

References (56)

1. Cosentino, S. et al. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 70, 1842-1849 (2008).
2. Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923 (1993).
3. Liu, F. et al. The apolipoprotein E gene and its age-specific effects on cognitive function. Neurobiol Aging 31, 1831-1833 (2010).
4. Blair, C. K. et al. APOE genotype and cognitive decline in a middle-aged cohort. Neurology 64, 268-276 (2005).
5. Rall, S. C., Jr., Weisgraber, K. H. & Mahley, R. W. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 257, 4171-4178 (1982).
6. Zannis, V. I., McPherson, J., Goldberger, G., Karathanasis, S. K. & Breslow, J. L. Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. J Biol Chem 259, 5495-5499 (1984).
7. Hartman, R. E. et al. Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp Neurol 170, 326-344 (2001).
8. Raber, J. et al. Apolipoprotein E and cognitive performance. Nature 404, 352-354 (2000).
9. Bu, G. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10, 333-344 (2009).
10. Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9, 106-118 (2013).
11. Hoe, H. S. et al. Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor. J Biol Chem 281, 3425-3431 (2006).
12. Herz, J. & Chen, Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci 7, 850-859 (2006).
13. Korwek, K. M., and Trotter, J. H., Ladu, M. J., Sullivan, P. M. & Weeber, E. J. ApoE isoform-dependent changes in hippocampal synaptic function. Mol Neurodegener 4, 21 (2009).
14. Chiu, H. Y., Lin, H. H. & Lai, C. C. Potentiation of spinal NMDA-mediated nociception by cocaine- and amphetamine-regulated transcript peptide via PKA and PKC signaling pathways in rats. Regulatory peptides 158, 77-85 (2009).
15. Martin, A. M. et al. The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors. J Biol Chem 283, 12004-12013 (2008).
16. Benarroch, E. E. NMDA receptors: recent insights and clinical correlations. Neurology 76, 1750-1757 (2011).
17. Clayton, D. A., Grosshans, D. R. & Browning, M. D. Aging and surface expression of hippocampal NMDA receptors. J Biol Chem 277, 14367-14369 (2002).
18. Magnusson, K. R., Nelson, S. E. & Young, A. B. Age-related changes in the protein expression of subunits of the NMDA receptor. Brain Res Mol Brain Res 99, 40-45 (2002).
19. Fukushima, H. et al. Upregulation of calcium/calmodulin-dependent protein kinase IV improves memory formation and rescues memory loss with aging. J Neurosci 28, 9910-9919 (2008).
20. Cohen, S. & Greenberg, M. E. Communication Between the Synapse and the Nucleus in Neuronal Development, Plasticity, and Disease. Annu Rev Cell Dev Biol 24, 183-209 (2008).
21. Li, B. et al. NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity. J Neurosci 29, 11965-11972 (2009).
22. Unoki, T. et al. NMDA receptor-mediated PIP5K activation to produce PI(4,5)P(2) is essential for AMPA receptor endocytosis during LTD. Neuron 73, 135-148 (2012).
23. Chen, Y., and Durakoglugil, M. S., Xian, X. & Herz, J. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci U S A 107, 12011-12016 (2010).
24. Hoe, H. S. et al. Effects of apoE on neuronal signaling and APP processing in rodent brain. Brain Res 1112, 70-79 (2006).
25. Ong, Q. R., and Chan, E. S., Lim, M. L., Cole, G. M. & Wong, B. S. Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice. Sci Rep 4, 8 (2014).
26. Riddell, D. R. et al. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 28, 11445-11453 (2008).
27. Sullivan, P.M. et al. Reduced levels of human apoE4 proteininananimal model of cognitive impairment. Neurobiol Aging 32, 791-801 (2011).
28. Paoletti, P., Bellone, C. & Zhou, Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14, 383-400 (2013).
29. Raman, I. M., Tong, G. & Jahr, C. E. Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron 16, 415-421 (1996).
30. Tingley, W. G. et al. Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 272, 5157-5166 (1997).
31. Montminy, M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66, 807-822 (1997).
32. Lee, H. K., Barbarosie, M., Kameyama, K., Bear, M. F. & Huganir, R. L. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405, 955-959 (2000).
33. Wang, Y., Briz, V., Chishti, A., Bi, X. & Baudry, M. Distinct Roles for mu-Calpain and m-Calpain in Synaptic NMDAR-Mediated Neuroprotection and Extrasynaptic NMDAR-Mediated Neurodegeneration. J Neurosci 33, 18880-18892 (2013).
34. Hoeflich, K. P. & Ikura, M. Calmodulin in action: diversity in target recognition and activation mechanisms. Cell 108, 739-742 (2002).
35. Roche, K. W., O'Brien, R. J., Mammen, A. L., Bernhardt, J. & Huganir, R. L. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16, 1179-1188 (1996).
36. Wan, X. Z. et al. Activation of NMDA receptors upregulates a disintegrin and metalloproteinase 10 via a Wnt/MAPK signaling pathway. J Neurosci 32, 3910-3916 (2012).
37. Xiao, L., Hu, C., Feng, C. & Chen, Y. Switching of N-methyl-D-aspartate (NMDA) receptor-favorite intracellular signal pathways from ERK1/2 protein to p38 mitogen-activated protein kinase leads to developmental changes in NMDA neurotoxicity. J Biol Chem 286, 20175-20193 (2011).
38. Sakamoto, K., Karelina, K. & Obrietan, K. CREB: a multifaceted regulator of neuronal plasticity and protection. J Neurochem 116, 1-9 (2011).
39. Makhinson, M., and Chotiner, J. K., Watson, J. B. & O'Dell, T. J. Adenylyl cyclase activation modulates activity-dependent changes in synaptic strength and Ca21/calmodulin-dependent kinase II autophosphorylation. J Neurosci 19, 2500-2510 (1999).
40. Raber, J. et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci U S A 95, 10914-10919 (1998).
41. Wang, C. et al. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. Neurobiol Dis 18, 390-398 (2005).
42. Holtzman, D. M., Herz, J. & Bu, G. Apolipoprotein e and apolipoprotein e receptors: normal biology and roles in Alzheimer disease. Cold Spring Harbor perspectives in medicine 2, a006312 (2012).
43. Grootendorst, J. et al. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav Brain Res 159, 1-14 (2005).
44. Leung, L. et al. Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice. PLoS One 7, e53569 (2012).
45. Weeber, E. J. et al. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277, 39944-39952 (2002).
46. Brodbeck, J. et al. Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors. J Biol Chem 286, 17217-17226 (2011).
47. Huang, Y. & Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222 (2012).
48. Lan, J. Y. et al. Protein kinase C modulates NMDA receptor trafficking and gating. Nat Neurosci 4, 382-390 (2001).
49. Nayak, A., and Zastrow, D. J., Lickteig, R., Zahniser, N. R. & Browning, M. D. Maintenance of late-phase LTP is accompanied by PKA-dependent increase in AMPA receptor synthesis. Nature 394, 680-683 (1998).
50. Sen, A., Alkon, D. L. & Nelson, T. J. Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon. J Biol Chem 287, 15947-15958 (2012).
51. Yu, Y. W., and Lin, C. H., Chen, S. P., Hong, C. J. & Tsai, S. J. Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neurosci Lett 294, 179-181 (2000).
52. Filippini, N. et al. Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage 54, 602-610 (2011).
53. Greenwood, P. M., Sunderland, T., Friz, J. L. & Parasuraman, R. Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene. Proc Natl Acad Sci U S A 97, 11661-11666 (2000).
54. Sweatt, J. D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76, 1-10 (2001).
55. Ji, R. R., Gereau, R. W. T., Malcangio, M. & Strichartz, G. R. MAP kinase and pain. Brain Res Rev 60, 135-148 (2009).
56. Sullivan, P. M. et al. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272, 17972-17980 (1997).